Cart
0

World HPV Therapeutic Vaccines Market - Opportunities and Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_181529
Pages: NA
Dec 2018 | 644 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Human papilloma virus (HPV) vaccines are used to protect against HPV infections. They are sexually transmitted through skin and mucous of the infected person. Sexually transmitted HPV infection can be categorized as low-risk HPVs and high-risk HPVs. Low-risk HPV causes skin warts around genitals, anus, mouth, or throat, and could lead to respiratory papillomatosis; whereas, high-risk HPV causes cancer such as cervical, anal, oropharyngeal cancers, and other rarer cancers. In the U.S., the incidence of genital HPV infections is approximately 14 million per year. HPV vaccination is used to prevent and reduce the risk of HPV infection. Increasing incidence of HPV is the major driving factor of the world HPV therapeutic vaccines market.

Currently, there are three FDA approved HPV vaccines available in the market, namely, Gardasil, Gardasil 9, and Cervarix. These vaccines are effective in preventing infections caused by two high-risk HPVs (HPV types 16 and 18), which are responsible for causing about 70% of cervical cancers. Rising incidence of HPV infections and growing concerns related to sexually transmitted diseases are expected to propel the market growth. Conversely, low adoption rate and stringent regulatory policies requiring long-term studies of vaccines and their efficacies hinder the market growth.

In this report, the world HPV therapeutic vaccines market is segmented on the basis of adjuvants and geography. Based on adjuvants, the market can be classified as bivalent HPV vaccine or the quadrivalent HPV vaccine. Based upon geography, world HPV therapeutic vaccines market is segmented into North America, Europe, Asia-Pacific and LAMEA.

On July 2016, China Food and Drug Administration has allowed pharmaceutical giant GlaxoSmithKline plc to sell Cervarix in China, thereby allowing the company to expand its market.
Major players operating in this market are Merck & Co., Inc. manufacturing Gardasil and Gardasil 9 and GlaxoSmithKline plc which manufactures Cervarix.

KEY MARKET BENEFITS:

  • This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2022, which assists in identifying the prevailing market opportunities.
  • Geographically, the market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
  • Competitive intelligence highlights the business practices followed by the leading players across various regions.
  • Recent developments in government policies on various segments is highlighted along with offering insight into the regulatory framework impacting the market.
  • The report offers an overview of changing market dynamics in terms of fast turn-around analysis of stakeholders responses to recent industry policy changes and trends.

HPV THERAPEUTIC VACCINES MARKET SEGMENTS:

By Adjuvants

  • Bivalent HPV Vaccine
  • Quadrivalent HPV Vaccine

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • France
    • Others
  • Asia
    • Japan
    • China
    • India
    • Others
  • LAMEA
    • Brazil
    • U.A.E
    • Africa
    • Others
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World HPV Therapeutic Vaccines Market- Opportunities and Forecast, 2014-2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo